Navigation Links
20-City Zagat Survey(R) Guide Spotlights Outdoor Destinations and Offers Allergy Management Tips

"Out & About with Allergies" Guide Now Available in Time for Spring Allergy


RESEARCH TRIANGLE PARK, N.C., March 11 /PRNewswire-FirstCall/ -- A special-edition Zagat Survey(R) guide, launched today, offers people with seasonal and year-round allergies an insider's view of the most exciting outdoor destinations in 20 US cities -- and tips on how to manage their allergy symptoms so they can enjoy being outside. The free guide is available at

Zagat Survey(R), the leading publisher of consumer-based leisure content, and GlaxoSmithKline, maker of the allergy medication Veramyst(TM) (fluticasone furoate) Nasal Spray, created Out & About with Allergies: An Insider's Guide to Enjoying the City. Actor and allergy sufferer James Denton of Desperate Housewives is helping introduce the guide in order to bring attention to seasonal allergies and to encourage other allergy sufferers to manage their symptoms so that they can better enjoy outdoor experiences.

"I suffer with seasonal allergies, so I know how important it is to manage my symptoms," Denton said. "And for people like me who love the outdoors, this special-edition Zagat Guide introduces new places you can really enjoy when your allergy symptoms are under control."

The guide covers chic restaurants with outdoor dining and rooftop bars as well as secluded gardens and walking paths in Atlanta, Boston, Chicago, Cincinnati, Dallas/Ft. Worth, Denver, Houston, Las Vegas, Los Angeles, Miami, New Orleans, New York, Orlando/Tampa, Philadelphia, Phoenix/Scottsdale, Salt Lake City, San Diego, San Francisco, Seattle and Washington, DC. Out & About with Allergies also features useful tips for managing seasonal and year-round allergy symptoms.

"People with allergies may feel miserable, particularly if they experience multiple symptoms that persist for weeks to a few months," said Mark Mehle, M.D., clinical assistant professor at Northeastern Ohio Universities College of Medicine. "Allergy symptoms -- stuffy nose and red, itchy watery eyes -- may cause people to avoid the outdoors just when the weather is at its best."

About Nasal Allergies

One of the most prevalent chronic diseases in the U.S., nasal allergies, also known as allergic rhinitis, affect up to 40 million people annually, including 10 to 30 percent of adults and up to 40 percent of children.

Nasal allergies refer to inflammation of the lining of the nose. Inflammation can be caused by allergies to pollen, animal dander, house dust mite or mold spores. People with nasal allergies tend to have stuffy, runny, and itchy noses, may sneeze a lot, or have red, itchy, watery eyes. Some people with nasal allergies suffer from seasonal allergies (or hay fever), while others have year-round allergies. Seasonal allergies are usually triggered by pollens, and as the name implies, occur during certain seasons and last a few weeks to a few months. Year-round allergy symptoms are triggered by dust mites, animal dander or mold.

About Veramyst

Veramyst Nasal Spray treats seasonal and year-round nasal allergy symptoms in adults and children 2 years and older.

For seasonal allergies, Veramyst helps patients twelve years and older treat multiple symptoms, such as sneezing, congestion, itchy and runny nose, and red, itchy and watery eyes with one medicine. For year-round allergies, Veramyst treats only nasal symptoms, including sneezing, congestion and itchy and runny nose.

For patients twelve years and older with seasonal allergies, Veramyst has also demonstrated improvement in overall allergy-related quality of life. However, for patients with year-round allergies, similar benefit has not been established.

Important Information about Veramyst

Side effects include nosebleed or nasal sores. Nasal fungal infection, glaucoma or cataracts may occur. Patients should have regular eye exams. Veramyst should not be sprayed in the eyes.

Available by prescription only. For best results use Veramyst once daily. Maximum relief may take several days. Individual results may vary.

About GlaxoSmithKline

GlaxoSmithKline (NYSE: GSK) is one of the world's leading research-based pharmaceutical and healthcare companies. GlaxoSmithKline is committed to improving the quality of human life by enabling people to do more, feel better, and live longer. For company information visit

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors
2. FDA Updates Prescription Guidelines for Blood Thinner
3. New Asthma Guidelines Stress Disease Control
4. Study finds primary care depression treatment often does not follow quality guidelines
5. Microarray provides 3 genomic guides to breast cancer treatment decisions
6. New lung cancer guidelines oppose general CT screening
7. New Lung Cancer Guidelines Oppose General CT Screening
8. OSHA Issues Draft Ergonomics Guidelines on Preventing Musculoskeletal Injuries in Shipyards
9. Proven Terumo Coronary Guidewire Technology Is Now Available in the United States
10. Long-awaited international ethical guidelines for biobank researchers
11. Internal medicine physicians recommend key elements to guide state initiatives
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
(Date:6/24/2016)... ... 24, 2016 , ... Today, MTI-GlobalStem, a provider of optimized ... difficult to transfect cells, announces its launch of the PluriQ™ G9™ Gene Editing ... is a complete system for culturing and transfecting human pluripotent stem cells ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... addition of the "Structural Electronics 2015-2025: Applications, ... In-Mold Electronics, Smart ... Integrated Photovoltaics Structural electronics involves ... as load-bearing, protective structures, replacing dumb structures such ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
Breaking Medicine Technology: